Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole and Terbinafine in Crohn's Disease
NCT05049525Phase 2Terminated
- Sponsor
- Montréal Heart Institute
- Start
- Feb 2022
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole, Terbinafine in Crohn's disease, sponsored by Montréal Heart Institute. Started Feb 2022; status: terminated.
02
Drugs
itraconazoleTerbinafine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT05049525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05049525.